Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
Apr, 21 2026
May, 23 2025
Mar, 27 2026
Oct, 5 2025
Dec, 28 2025